SUMMARY Extraintestinal pathogenic Escherichia coli (ExPEC) strains are responsible for a
majority of human extraintestinal infections globally, resulting in enormous direct medical …

In 2008, a previously unknown Escherichia coli clonal group, sequence type 131 (ST131),
was identified on three continents. Today, ST131 is the predominant E. coli lineage among …

Background The global emergence and spread of extended-spectrum beta-lactamases
(ESBLs) producing Enterobacteriaceae have been threatening the ability to treat an …

Multilocus sequence typing reveals that many bacterial species have a clonal structure and
that some clones are widespread. This underlying phylogeny was not revealed by pulsed …

Production of extended-spectrum β-lactamases (ESBLs) is the principal mechanism of
resistance to oxyimino-cephalosporins evolved by members of the family …

Pathogenic Escherichia coli strains cause a wide variety of intestinal and extraintestinal
infections. The widespread geographical clonal dissemination of intestinal pathogenic E …

To understand the dynamics behind the worldwide spread of the mcr-1 gene, we determined
the population structure of Escherichia coli and of mobile genetic elements (MGEs) carrying …

Most human extraintestinal Escherichia coli infections, including those involving
antimicrobial resistant strains, are caused by the members of a limited number of distinctive …

Abstract Treatment of community urinary tract infections (UTIs) caused by extended-
spectrum β lactamase (ESBL)-producing Escherichia coli (E. coli) is more expensive than …

Food producing animal is a global challenge in terms of antimicrobial resistance spread.
Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae are relevant …